| 000 | 01632 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517212535.0 | ||
| 264 | 0 | _c20190111 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1878-5492 | ||
| 024 | 7 |
_a10.1016/j.trim.2018.04.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Heiden, P L J | |
| 245 | 0 | 0 |
_aCMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity. _h[electronic resource] |
| 260 |
_bTransplant immunology _c08 2018 |
||
| 300 |
_a54-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlemtuzumab _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aCytomegalovirus _xphysiology |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity |
| 650 | 0 | 4 | _aImmunologic Memory |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aStem Cell Transplantation |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aVirus Activation |
| 700 | 1 | _avan Egmond, H M | |
| 700 | 1 | _aVeld, S A J | |
| 700 | 1 | _avan de Meent, M | |
| 700 | 1 | _aEefting, M | |
| 700 | 1 | _ade Wreede, L C | |
| 700 | 1 | _aHalkes, C J M | |
| 700 | 1 | _aFalkenburg, J H F | |
| 700 | 1 | _aMarijt, W A F | |
| 700 | 1 | _aJedema, I | |
| 773 | 0 |
_tTransplant immunology _gvol. 49 _gp. 54-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.trim.2018.04.003 _zAvailable from publisher's website |
| 999 |
_c28311151 _d28311151 |
||